English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Bitter melon is a medicinal plant with wide-ranging health benefits. Being complex in chemical constituents, poor evidence is available to establish the exact therapeutic benefits of different phytochemicals present in bitter melon. In the present study, bitter melon fruit skin, flesh, seeds and whole fruit were assessed to estimate alkaloid and saponin contents and subsequently bio-evaluation was performed to ascertain their potential as more potent hyperglycemic and hyperlipidemic moderators for the first time. For the feeding trial, Sprague-Dawley rats were used. Bitter melon seeds have a high amount of total alkaloids, while the flesh part has maximum total saponin contents. The group of rats fed with a diet containing seeds powder showed a more prominent impact in lowering blood glucose levels and increasing serum insulin concentration in hyperglycemic and hyperlipidemic rats. The flesh part with maximum saponin contents exhibited a substantial impact in lowering cholesterol, LDL and triglycerides and increasing HDL levels. The antihyperglycemic and antihyperlipidemic activities have a direct association with the presence of these chemical constituents. Alkaloids were found to be more potent antihyperglycemic while saponins were found to be antihyperlipidemic moderators.

Bio-evaluation of alkaloids and saponins from bitter melon: Probing more desirable compound in treating hyperglycemia and hyperlipidemia